Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans.
Fleroxacin (Ro 23-6240; AM-833) is a new trifluorinated quinolone exhibiting high activity against a broad spectrum of gram-negative and gram-positive bacteria. Healthy male volunteers received, according to a randomized scheme, oral doses of 200, 400, or 800 mg of fleroxacin in tablet form, an intr...
Spremljeno u:
| Izdano u: | Antimicrob Agents Chemother |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Microbiology (ASM)
1987
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC175826/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3125788/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.31.12.1909 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|